Identifying cases of Takotsubo cardiomyopathy in Scotland
Official title: Establishing the Incidence of Tako-tsubo Cardiomyopathy in Scotland - the STARR Study
Run by University of Aberdeen · NCT03299569 · Data updated 2026-11-12
This study is trying to find out how many people in Scotland have Takotsubo cardiomyopathy, a stress-related heart condition, and how it affects their health compared to others with heart issues.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 800 (estimated) |
| Sponsor | University of Aberdeen Academic / other |
| Locations | 1 site (Aberdeen, Scotland) |
| Status | Recruiting |
| Started | July 29, 2016 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2028 |
| Registry record updated | September 9, 2026 |
| Trial ID | NCT03299569 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals diagnosed with Takotsubo cardiomyopathy.
✕Probably not a fit
Patients who do not have a diagnosis of Takotsubo cardiomyopathy will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to establish the incidence of Takotsubo cardiomyopathy, a condition that mimics a heart attack but is triggered by acute stress, in Scotland since 2010. Public Health Scotland will identify patients diagnosed with this condition using specific health codes and will cross-check their clinical data to confirm diagnoses. The study will also create a registry of confirmed Takotsubo cases and compare clinical outcomes with matched control populations, including individuals from the general population and patients with myocardial infarction. Data will be collected both retrospectively and prospectively to assess outcomes and treatment patterns.
Why it matters
Potential benefit: If successful, this study could enhance understanding of Takotsubo cardiomyopathy and improve patient management strategies.
How similar studies have gone: While this study focuses on incidence and epidemiology, similar studies have shown success in understanding the outcomes of Takotsubo cardiomyopathy.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients diagnosed with Takotsubo cardiomyopathy Exclusion Criteria: * NA
Where it's running
-
Cardiac Research Office
Aberdeen, Scotland, United Kingdom Recruiting
Study contacts
- Principal investigator: Dana Dawson, MD, MRCP — University of Aberdeen
- Study coordinator: Dana Dawson, MD, MRCP
- Email: dana.dawson@abdn.ac.uk
- Phone: 01224 437969
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Heart@Home: Safe, at-home care for people with acute heart problems compared with hospital care
This trial tests whether hospital-level care at home can safely and effectively treat adults with acute heart conditions who would normally be in the hospital.
-
Digital cardiac rehab to help heart attack patients improve function
A digital health–supported cardiac rehabilitation program is being tested to see if it helps people after a heart attack improve fitness and stay engaged with rehab, compared with standard outpatient rehab.
-
NMR-based Risk Test and Digital Health Support for midlife adults in Eloisa
This study tests whether an NMR metabolomics risk test can guide tailored digital health programs for midlife adults at risk of diabetes, heart disease, stroke, kidney disease, or fatty liver.
-
See if stopping long-term aspirin is as good as continuing it in older adults with stable ischemic heart disease
In adults 65 and older with stable ischemic heart disease, this trial tests whether stopping daily low-dose aspirin is not worse than continuing it.
-
Innate Immune Cells and Early Fibrotic Repair After a Heart Attack
This study tests whether specific neutrophil and monocyte patterns are linked to early scar formation after a heart attack in STEMI patients.
-
Remote Balance in Everyday Life for young MI patients with distress
This study tests a remote 6-session program (rBEL) to help adults under 55 who had a heart attack and feel distressed see if the program and study procedures are feasible.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.